C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2002
11/12/2002	US6479482 Alkylamine derivatives of dihydropyridine NPY antagonists
11/07/2002	WO2002088298A1 Compounds, compositions, and methods for controlling biofilms
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002	US20020165396 Novel opiate compounds, methods of making and methods of use
11/07/2002	US20020165395 Substituted piperidine derivatives
11/07/2002	US20020165240 Method of treating proliferative diseases using Eg5 inhibitors
11/07/2002	US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/07/2002	US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165201 Cyanoguanidine prodrugs
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/07/2002	US20020165096 Applying to weeds
11/07/2002	CA2445591A1 Nitrogen heterocyclic compounds and compositions for controlling biofilms
11/06/2002	WO2001060799A1 Resolution of the enantiomers of amlodipine
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254661A1 Method for preventing dyskinesias with selective NMDA-Antagonists
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254104A1 Quaternary ammonium compounds and their use as anti-tussive agent
11/06/2002	EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1377868A Method for reducing N oxo-compound
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/05/2002	WO2001085673A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476228 Process for producing piperidinecarbinols
11/05/2002	US6476227 Piperidine derivative and process for preparing the same
11/05/2002	US6476067 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2002	US6476058 Methods of pharmacological treatment using S(−) amlodipine
11/05/2002	US6476054 Cyclic amine modulators of chemokine receptor activity
11/05/2002	US6476053 Mycobacterial inhibitors
11/05/2002	US6476050 3-substituted piperidines comprising urea functionality, and methods of use thereof
11/05/2002	US6476027 N-hydroxy 4-sulfonyl butanamide compounds
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	CA2408209A1 Phenyl-substituted 2-enamino-keto nitriles
10/2002
10/31/2002	WO2002086138A2 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002	US20020161240 Synthetic multimerizing agents
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161075 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds
10/31/2002	US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002	US20020160988 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
10/31/2002	DE10120819A1 Preparation of 4-haloalkyl-nicotinonitrile, useful as a pesticide intermediate, comprises reacting 3-amino-1-haloalkyl-2-propenone with nitrile and cyclizing the novel 3-oxo-haloalkenylamino-substituted nitrile intermediate
10/31/2002	CA2444599A1 Melanocortin receptor ligands
10/31/2002	CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/30/2002	WO2001083444A1 Method for producing cyclic lactams
10/30/2002	EP1252152A1 Urea compounds as inhibitors for vla-4
10/30/2002	EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002	EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002	EP1252141A1 Tosylproline analogs as thymidylate synthase inhibitors
10/30/2002	EP1137416B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
10/30/2002	EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002	EP0879228B1 Process for the preparation of d-threo-(r,r)-methyl phenidate and recycling of undesired enantiomers by epimerisation
10/30/2002	EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CA2407813A1 Method for producing cyclic lactams
10/29/2002	US6472529 Viricides
10/29/2002	US6472505 Treatment of physiological conditions capable of being modulated by agonist or antagonist activity on parathyroid hormone receptors
10/29/2002	US6472456 Polyolefins, especially polypropylene, can be made flame retardant by the incorporation therein of a synergistic mixture of a selected hindered amine substituted by an alkoxy, cydoalkoxy or hydroxyalkoxy moiety and a selected
10/29/2002	US6472422 Treating drug addiction
10/29/2002	US6472410 N-cyclopentyl modulators of chemokine receptor activity
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002	US6472394 MCH antagonists and their use in the treatment of obesity
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/24/2002	WO2002083781A1 Long chain hindered amines and compositions stabilized therewith
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083641A2 Amino-aza-cyclohexanes for the treatment of malaria
10/24/2002	WO2002083630A1 Oxalic acid derivatives
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083175A1 Visual function improving agents
10/24/2002	WO2002083134A1 Aryl and biaryl piperidines used as mch antagonists
10/24/2002	WO2002083071A2 Heterocyclic analgesic compounds and methods of use thereof
10/24/2002	WO2002083062A2 Process for the production of piperidine derivatives with microorganisms
10/24/2002	WO2002030897A3 Compositions and methods for regulating the nervous system
10/24/2002	US20020156314 Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
10/24/2002	US20020156109 1,4-dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156100 1-deoxy-galactonojirimycin and related compounds used to treat fabry disease
10/24/2002	US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
10/24/2002	CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002	CA2445538A1 Oxalic acid derivatives
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/23/2002	EP1250927A2 Pharmaceutical composition for topical application comprising nifedipine
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1250317A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
10/23/2002	EP0909298B1 Stabilisation of paints with spiroindane derivatives
10/23/2002	CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/23/2002	CA2381630A1 Method for preventing dyskinesias
10/22/2002	US6469193 Efficient synthesis of alkyl carbonates
10/22/2002	US6469173 Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates
10/22/2002	US6469065 Compound that donates, transfers or releases nitric oxide, elevates endogenous levels of nitric oxide

1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 380